Scientists stunned: New vaccine shows hope against deadliest breast cancer
An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in clinical trials. The vaccine aims to train the immune system to recognise and attack cancer cells, potentially reducing recurrence and improving survival with fewer side effects than chemotherapy. Larger trials are now planned to confirm these promising findings.
An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in clinical trials. The vaccine aims to train the immune system to recognise and attack cancer cells, potentially reducing recurrence and improving survival with fewer side effects than chemotherapy. Larger trials are now planned to confirm these promising findings.
